Literature DB >> 2983120

Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies.

P A Offit, H F Clark.   

Abstract

Newborn mice suckled on dams immunized either orally or parenterally with primate rotavirus SA-11 were protected against diarrhea induced by SA-11 virus challenge. Experimental oral administration of milk from orally immunized dams protected suckling mice against challenge; protective activity was detected both in the anti-rotavirus immunoglobulin A (IgA) and IgG fractions, but IgA was more potent in vivo than IgG. Oral administration of milk from parentally immunized dams also protected suckling mice against challenge; in this case, protective activity was detected in the anti-rotavirus IgG fraction. In newborn mice foster-nursed by seronegative dams, circulating rotavirus-specific antibodies in high titer did not protect mice against oral SA-11 virus challenge. It appears that the most effective rotavirus vaccine will be that which induces an efficient production of antibodies active at the intestinal cell surface.

Entities:  

Mesh:

Year:  1985        PMID: 2983120      PMCID: PMC254760     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Studies in shigellosis. III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment.

Authors:  A R HIGGINS; T M FLOYD; M A KADER
Journal:  Am J Trop Med Hyg       Date:  1955-03       Impact factor: 2.345

2.  Detection of antibody to rotavirus by counterimmunoelectrophoresis in human serum, colostrum, and milk.

Authors:  D A Cook; A Zbitnew; G Dempster; J W Gerrard
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

3.  Bacterial and viral coproantibodies in breast-fed infants.

Authors:  J F Kenny; M I Boesman; R H Michaels
Journal:  Pediatrics       Date:  1967-02       Impact factor: 7.124

4.  Passive immunity in transmissible gastroenteritis of swine: immunoglobulin characteristics of antibodies in milk after inoculating virus by different routes.

Authors:  E H Bohl; L J Saif
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

5.  Virus-specific immunity in neonatal and adult mouse rotavirus infection.

Authors:  J F Sheridan; R S Eydelloth; S L Vonderfecht; L Aurelian
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

6.  Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance.

Authors:  A Z Kapikian; R G Wyatt; M M Levine; R H Yolken; D H VanKirk; R Dolin; H B Greenberg; R M Chanock
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

7.  Pathogenesis of rotavirus infection in mice.

Authors:  L M Little; J A Shadduck
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

8.  Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque reduction neutralization.

Authors:  P A Offit; H F Clark; S A Plotkin
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

9.  Diarrhea among infants and young children in Canada: a longitudinal study in three northern communities.

Authors:  M Gurwith; W Wenman; D Gurwith; J Brunton; S Feltham; H Greenberg
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

10.  Studies on the etiology and transmission of epidemic diarrhea of infant mice.

Authors:  L M KRAFT
Journal:  J Exp Med       Date:  1957-11-01       Impact factor: 14.307

View more
  57 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  Porcine epidemic diarrhea: a review of current epidemiology and available vaccines.

Authors:  Daesub Song; Hyoungjoon Moon; Bokyu Kang
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

3.  Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes.

Authors:  P A Offit; K I Dudzik
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Rotavirus virus-like particles administered mucosally induce protective immunity.

Authors:  C M O'Neal; S E Crawford; M K Estes; M E Conner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Serum IgG mediates mucosal immunity against rotavirus infection.

Authors:  Larry E Westerman; Harold M McClure; Baoming Jiang; Jeffrey W Almond; Roger I Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

Review 6.  Control of viral disease: the development of Epstein-Barr virus vaccines.

Authors:  A J Morgan
Journal:  Springer Semin Immunopathol       Date:  1991

7.  Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion.

Authors:  Blaise Corthésy; Yann Benureau; Clémentine Perrier; Cynthia Fourgeux; Nathalie Parez; Harry Greenberg; Isabelle Schwartz-Cornil
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

8.  Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7.

Authors:  P A Offit; R D Shaw; H B Greenberg
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

9.  Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams.

Authors:  Alexander J Bondoc; Mubeen A Jafri; Bryan Donnelly; Sujit K Mohanty; Monica M McNeal; Richard L Ward; Greg M Tiao
Journal:  J Pediatr Surg       Date:  2009-08       Impact factor: 2.545

10.  Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches.

Authors:  K J Silvey; A B Hutchings; M Vajdy; M M Petzke; M R Neutra
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.